Business
ImmunityBio to Participate in 35th Annual Piper Sandler Healthcare Conference
CULVER CITY, Calif.--(BUSINESS WIRE)-- ImmunityBio, Inc. (NASDAQ: IBRX), a clinical-stage immunotherapy company, announced today that the company will be
About this update from Immunitybio, Inc.
[{"type":"text","content":" CULVER CITY, Calif.--(BUSINESS WIRE)--\n\nImmunityBio, Inc. (NASDAQ: IBRX), a clinical-stage immunotherapy company, announced today that the company will be participating in the 35th Annual Piper Sandler Healthcare Conference, which is taking place in New York City, November 28-30, 2023.\n\n\nDetails of the presentation can be found below.\n\n\n\n\nPiper Sandler Healthcare Conference\n\n\n\n\n\n\n\n\nDate\n\n\n\n\n\n \n \n\nThursday, November 30, 2023\n\n\n\n\n\n\n\n\nTime:\n\n\n\n\n\n \n \n\n10:30 am EST\n\n\n\n\n\n\n\n\nFormat:\n\n\n\n\n\n \n \n\nFireside chat with Director and Senior Research Analyst Joseph Catanzaro, Ph.D.\n\n\n\n\n\n\n\n\nWebcast Link: https://event.webcasts.com/starthere.jsp?ei=1644522&tp_key=54f83a05b0\n\n\n\n\n\n\n\nA replay of the presentation will be available by visiting the \"Events” section of the ImmunityBio website and will be archived for 90 days.\n\n\nAbout ImmunityBio\n\n\nImmunityBio is a vertically-integrated, clinical-stage biotechnology company developing next-generation therapies and vaccines that bolster the natural immune system to defeat cancers and infectious diseases. The company’s range of immunotherapy and cell therapy platforms, alone and together, act to drive and sustain an immune response with the goal of creating durable and safe protection against disease. We are applying our science and platforms to treating cancers, including the development of potential cancer vaccines, as well as developing immunotherapies and cell therapies that we believe sharply reduce or eliminate the need for standard high-dose chemotherapy. These platforms and their associated product candidates are designed to be more effective, accessible, and easily administered than current standards of care in oncology and infectious diseases.\n\n\nFor more information, please visit: www.immunitybio.com\n\n\nForward Looking Statements\n\n\nThis press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, such as statements regarding conference participation and timing, the development of therapeutics for cancers and infectious diseases, ImmunityBio’s product candidates as compared to existing treatment options, and the regulatory review process, among others. Statements in this press release that are not statements of historical fact are considere...